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Abstract 
 
 
 
ECONOMIC IMPACT OF WASTE IN PRESCRIBING, DISPENSING, AND 
MEDICATION CONSUMPTION IN THE UNITED STATES 
 
By Sarah A. Almanie, M.S. 
 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of 
Science at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2015. 
 
Major Director: David A. Holdford, R.Ph., M.S., Ph.D., FAPhA 
Professor 
Department of Pharmacotherapy and Outcomes Science 
 
 
 
OBJECTIVES: This research examines waste associated with the medication use 
process which consists of unfilled prescriptions, abandoned prescriptions, or unused 
prescription medications. The aim of this study is to quantify the direct medical costs of 
medication waste in delivery of care in the United States.  
METHODS: A review of published literature and data from the 2012 Medical 
Expenditure Panel Survey was used to quantify the number of prescriptions wasted at 
different stages of the medication prescribing and use process and the associated costs 
were calculated.
 
   
   
 
RESULTS: In 2012, more than 26 million prescriptions were either unfilled or 
abandoned, and more than 225 million resulted in dispensed medications that were not 
used. The total cost of this waste was estimated at $30.4 billion.  
CONCLUSIONS: Patients who do not fulfill their role in the medication use process 
cause significant, avoidable costs to the health care system beyond the health 
outcomes not achieved. 
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Chapter 1 
 
 
 
Section1.1: Background 
 
 
 
     Medicines constitute a major role in the treatment of many diseases; however, not all 
medications are consumed by patients.  When they are not consumed, they are wasted 
and can become a risk to humans and the environment. The risks of drug waste come 
from three primary sources: storage, disposal, and nonuse. 
Storage 
     Improperly stored medications in households can cause harm in several ways. One 
way is that children may accidentally ingest medications stored in the home and be 
poisoned. Another way is by diversion of stored medications for recreational use. This 
can occur when young family members experiment with other family members’ 
controlled substances or when leftover medications are shared with friends or family 
members. Finally, stored medicines in the home provide an option for suicide attempts 
among individuals. 
     Studies support the potential harm from stored medications. A survey of emergency 
room visits revealed that the number of visits due to non-medical use of prescription 
drugs and over the counter medications equaled 1.2 million in 2009, half of which
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was attributed to opioid analgesics.1 A report from the centers for disease control (CDC) 
in 2009 also showed that about 91% of unintentional poisoning deaths in the U.S. were 
caused by drug overdoses, commonly, prescription opioids.2 
Disposal 
     Drug disposal is another risk from drug waste. Improper disposal of drugs can make 
it into the sewage system and eventually the nation's water supply.  A report from the 
Associated Press showed that prescription drugs were found in the drinking water for 24 
major metropolitan areas across the United States.3 Analysts attributed such water 
contamination to the improper disposal of unused medications by humans. Another 
study in New York state investigated the presence of pharmaceuticals in two 
wastewater treatment plants between the years 2004-2009 and found that processed 
wastewater from factories contained high concentrations of opioids and muscle 
relaxants.4 Although the risk to humans of drugs in groundwater is not clear, the impact 
on marine mammals is more apparent. In 2012, the U.S. geological survey reported a 
high prevalence of fish intersex was seen in the Potomac River watershed. Fish intersex 
occurs when female fish experience male characteristics and vice versa. Investigators 
related such mutations to the presence of hormonal medicines in water.5 
Nonuse 
     Opportunity costs are associated with prescribed medications that are not used by 
patients as directed. A report from IMS Health, revealed that around $213 billion in the 
United States was wasted in 2012 on prescribed medications. A breakdown of costs 
showed that approximately half of these avoidable costs were associated with patients 
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who don’t refill their medications, don’t take their medications as directed, or develop 
health complications requiring treatment.6  
     Other research illustrates the costs of medication waste. In a single hospice program 
(2005), it was found that the average cost of medications left at death by 100 patients 
was between $100 and $200 per patient.7 In 2010, the total amount of prescribed 
medications collected in a national prescription take back event was more than 121 
tons.8  
Defining "Medication Waste" 
     The literature provides no consistent definition of medication waste, making it difficult 
to quantify the problem and compare studies. According to Oxford dictionary, “waste” is 
defined as “an act or instance of using or expending something carelessly, 
extravagantly, or to no purpose”.9 This definition indicates that anything that is used 
carelessly, inefficiently, or ineffectively is waste.  
 In the literature, medication waste has a variety of definitions. These include:  
     1.   “medicines issued to the patient but not consumed”,10  
2. “any drug product, either dispensed by a prescription or purchased over the 
counter (OTC), that is never fully consumed”,11 
3. “items which have been dispensed but are unused or partly used by patients and 
eventually need to be disposed”,12  
4. “the consequence of an inappropriate disposal of unused or partially used 
ampoules, vials, or syringes of drugs”,13  
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5. and “medication that has been spilled, has been rejected for use by the patient, 
or otherwise cannot be returned to the pharmacy for reuse”.14  
     There is a general agreement among these definitions that describes medication 
waste as unconsumed or unused medications. However, the definitions differ in the 
types of medications being wasted, the intended population, the underlying cause of 
wastage, and the way medicines are wasted. Some definitions include over the counter 
medications while others are limited to prescription medications. Certain definitions 
focus on outpatient populations and others target inpatient medication waste.  Some 
definitions are limited to waste caused by a patient’s refusal to take the medication or a 
left over dose while others are non-specific. Definitions also vary in how medications are 
wasted (e.g., improper disposal).   
     The consequences of medication waste are another source of variation in the 
literature. Studies of medication waste differ on the degree to which they examine 
impact on health outcomes, health of environmental ecosystems, and financial costs 
after being dispensed by pharmacy personnel. In addition, costs incurred prior to 
dispensing are not quantified such as preparation costs for each medication not picked 
up by a patient. In these cases, waste of labor occurs.  
     This research provides an operational definition of medication waste that focuses on 
medication use in community settings but expands on the definition of waste to include 
cost of labor.  In this study, medication waste is defined as: 
 “resource use associated with unfilled, abandoned prescriptions and 
prescription medications that are not consumed by patients in the 
community”.  
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     This definition focuses on medication use that is primarily within the control of the 
end consumer (patients) and excludes waste in institutional settings which may occur 
for reasons unrelated to patient actions (e.g., spilled chemotherapy, changes in 
medication orders resulting in disposal).  In the community, patients make most 
decisions on where to store medications, how to dispose of them, and whether to take 
them or not.  In institutional inpatient settings, these choices are typically up to health 
care professionals. 
     The basic elements of medication waste in this study's definition are unfilled 
prescriptions, abandoned prescriptions, and unused prescription medications in 
outpatient settings. Unfilled prescriptions are those which are prescribed but not 
transmitted to the pharmacy for preparation. Unfilled prescriptions waste the time and 
resources of prescribers and their support personnel -- time that can be spent on 
productive activities, i.e. opportunity cost. Abandoned prescriptions are transmitted or 
delivered to the pharmacy but not picked up by the patient. They waste time and 
resources of both prescribers and pharmacy personnel. Unused prescription 
medications are dispensed but not taken by patients as directed. They waste time and 
efforts of prescribers and pharmacy personnel, and they waste medications.
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Section 1.2: Objectives 
 
 
 
     The main aim of the study is to estimate the direct medical costs in the United States 
associated with unfilled prescriptions, abandoned prescriptions, and unused prescription 
medications in outpatient settings, excluding any impact on health outcomes. Thus, our 
study focuses on wastage in delivery of care but not the impact on patient health 
outcomes. The population of interest is ambulatory (out-patient) individuals who receive 
their medications in community pharmacy settings in the United States including 
pharmacy chains, independent pharmacies, mail order, large discount department and 
warehouse stores, grocery stores, outpatient clinics, specialty pharmacies, emergency 
department pharmacies. Hospital pharmacies that serve inpatients and long term care 
pharmacies were excluded from the study because they represent a separate setting 
which is subjected to different rules and regulations. 
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Specific aim I: 
To estimate the annual direct medical costs of medication waste in delivery of care as a 
result of unfilled and abandoned prescriptions. 
Specific aim II: 
To estimate the annual direct medical costs of medication waste in delivery of care as a 
result of unused prescription medications.
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Section 1.3: Rationale 
 
 
 
     Medication waste is a worldwide problem that is not only associated with financial 
impact. It also negatively impacts safety, health and environment. Better understanding 
the problem can enable the healthcare system, patients and society to intervene and 
minimize the scope of the problem. Our study will contribute to the literature by 
examining medication waste from a different perspective. It will study the wasted inputs 
of the medication delivery system.  
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Section 1.4: Conceptual Framework 
 
 
 
     Waste associated with the medication use process consists of any written 
prescriptions that are (1) not taken to a pharmacy to be filled, (2) taken to be filled but 
abandoned at the pharmacy, or (3) dispensed but not consumed as directed. The 
economic burden of medication waste is assessed from a societal perspective. When a 
societal perspective is used, three main types of costs are typically considered: direct 
costs, indirect costs, and intangible costs (summarized in Table 1.1). However, in the 
current study we are interested in waste in medication therapy delivery so, only 
physician visit costs, dispensing costs, and prescription ingredient costs will be 
examined. In other words, this research focuses on input costs associated with delivery 
of medication therapy to patients (e.g., waste in time and effort, drugs) and excludes 
output costs resulting from the delivery of medications (e.g., resource use associated 
with negative health outcomes, lost productivity, , mortality, and morbidity). Figure 1.1 
illustrates the conceptual model used in this study.
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 Table 1.1 Types of costs associated with societal perspective 
Type of cost Example Costs related to our 
research  
Direct medical cost 
associated with delivery 
of medication therapy 
Input costs: 
- Outpatient physician’s 
visit cost 
- Dispensing cost 
- Prescription cost* 
 
          
          
          
          
Direct medical cost 
associated with failures 
in medication therapy 
Output costs**: 
- Hospitalization cost 
- Emergency department 
visit cost 
- Outpatient physician’s 
visit cost 
- Pharmacy cost 
 
 
Direct non-medical cost Transportation cost 
Disposal cost 
 
 
Indirect cost Loss of productivity 
 
 
Intangible cost Feeling 
Dissatisfaction 
Confusion 
 
 
Other societal cost Environmental cost 
 
 
* Prescription cost = dispensing cost + ingredient cost 
**Costs related to deterioration in health condition associated with medication waste 
 
     The first step in the model occurs when a physician prescribes a medication for use 
by a patient. In many cases, the prescription is sent electronically, by phone, or by fax 
transmission to be automatically prepared (filled) by the pharmacist for pickup by the 
patient. In some cases, the physician gives the patient a hand written prescription to be 
dropped off at a pharmacy. Many of these prescriptions are taken to the pharmacy to be 
filled but not all of them. Some are never taken by the patient to be filled in a pharmacy 
(not filled). Prescriptions that are delivered and filled at the pharmacy can either be 
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dispensed to the patient (picked up) or left at the pharmacy by the patient (abandoned). 
A prescription that is abandoned for a defined period of time (usually two weeks) will be 
returned to stock. If the patient picks up the prescription from the pharmacy, the 
prescribed medication will either be used as directed (used) or not used as directed (not 
used). Medications that are not used as directed may be used in way that was not 
prescribed or they may not be used at all.  
     At each step of the prescription writing and filling process, costs are incurred due to 
personnel time and effort, supplies, and medication. Any resources used that do not 
result in a medication being taken as directed are considered waste. In the base case of 
this model, refill orders which don’t require a physician visit are not considered.  
          
Figure1.1 Model of the medication use process: underlined words represent points 
where direct medical costs are incurred. 
Physician 
writes a 
prescription
Filled
Abandoned
Returned to 
stock (RTS)
Picked up
Used
Not used
Not filled
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Chapter 2 
 
 
 
Systematic Literature Review on the Economic Burden of Medication Waste 
 
 
 
     A systematic literature review on the economic burden of medication prescriptions 
waste was completed on October, 2014. The three databases examined were 
PubMed/MEDLINE (limited to abstract available, English, and humans), Cumulative 
Index to Nursing and Allied Health Literature (CINHAL) and International 
Pharmaceutical Abstracts (IPA). The following inclusion and exclusion criteria were 
considered in the literature search: 
Inclusion criteria 
Original studies that: 
1. Evaluated costs attributed to medication prescriptions waste (prescriptions not 
taken to a pharmacy to be filled, taken to be filled but abandoned at the 
pharmacy, or dispensed but not consumed as directed)  
2. Quantified the rate or prevalence of unfilled prescriptions, abandoned 
prescriptions, and prescriptions dispensed but not consumed as directed 
3. Identified reasons or predictors of medication prescription waste 
4. Assessed patient, providers, and prescriptions characteristics associated with 
medication prescriptions waste 
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Exclusion criteria: 
1. Evaluated environmental or safety/health related effects of medication waste 
2. Research was not conducted in the United States 
3. Evaluated medication waste for inpatient hospital settings, nursing homes and 
long term care facilities  
4. Studied pediatric populations: this population was excluded because the current 
research focuses on patient role in leading to medication waste and children 
have a minimum or no control on their actions   
     The literature review was divided into two parts. The first part reviewed the literature 
on unfilled and abandoned prescriptions. The second part reviewed literature on 
medications that are picked up but not consumed as directed.  
Part 1: Literature review of unfilled and abandoned prescriptions 
 
     Search terms used are summarized in Table 2.1. Titles and abstracts of articles were 
checked for inclusion and exclusion criteria. The original 1499 articles were reduced to 
75 after applying inclusion and exclusion criteria and eliminating duplicates.15-89 Of 
these, 11 articles were selected for discussion based on the following criteria:  
- Evaluated cost of unfilled prescriptions, abandoned prescriptions, or 
unconsumed prescription medications 
- Most recent studies 
- Not specific to a disease condition 
- More general settings compared to other studies 
 
   
14 
 
     References from the included articles were also reviewed, yielding two relevant 
studies.90,91 Literature search and selected articles are summarized in Figure 2.1 and 
Table 2.2, respectively.
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Table 2.1 Search terms history for unfilled and abandoned prescriptions 
Search term Eligible articles 
  
 
Primary non-adherence 
Abandoned prescriptions 
Unfilled prescriptions 
Unclaimed prescriptions 
Filling and prescriptions 
Cost and abandoned prescriptions 
Costs and abandoned prescriptions 
Cost and primary non adherence 
Costs and primary non-adherence 
Cost and abandoned and prescriptions 
Costs and abandoned and prescriptions 
Total unique eligible articles 
PubMed  
6 
3 
2 
8 
21 
2 
1 
1 
1 
2 
1 
 
CINHAL 
3 
3 
2 
1 
13 
1 
- 
- 
- 
1 
- 
 
 
IPA 
1 
2 
3 
27 
21 
1 
1 
- 
- 
1 
1 
75 
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Figure 2.1 Flow chart summary of literature search* 
*Adapted from: Sattler EL, Lee JS, Perri M,3rd. Medication (re)fill adherence measures 
derived from pharmacy claims data in older Americans: a review of the literature. Drugs 
Aging. 2013;30:383-399.
Articles retrieved based on search 
terms 
n= (1499) 
Eligible articles 
n= (130) 
Excluded articles that didn’t met 
the inclusion/exclusion criteria 
n= (1369) 
 
 
 
Eliminated duplicates 
n= (51) 
 
 
Unique eligible research articles 
n= (79) 
Excluded reports and review 
articles 
n= (4) 
 
 
Unique eligible original research 
articles 
n= (75) 
Articles selected for discussion  
n= (11): 
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Table 2.2 Summary of included articles of unfilled and abandoned prescriptions 
Author Study design and 
sample 
Sample size Outcome 
measure of 
interest to our 
model 
 
Period Setting and 
data source 
Findings relating 
to our research 
Shrank 
et al 2010 
 
 
- Cross sectional 
cohort study 
- All filled 
prescriptions within 
3 months period 
10,349,139 
prescriptions 
Rate of: 
1. Picked-up 
prescription 
2.Abandoned 
prescription with 
RTS* 
3.Abandoned 
prescription with 
RTS* then fill 
 
Two weeks - CVS retail 
pharmacy 
chain 
- Pharmacy 
data (CVS) 
- PBM data 
(Caremark) 
 
 
- Total abandoned 
prescriptions: 
3.27% 
- Abandoned 
prescription with 
return to stock: 
1.77% 
- Abandoned 
prescription with 
return to stock then 
filled: 1.5% 
 
Bergeron 
et al 2013 
- Cross sectional 
survey 
- Adults (≥ 18 years 
old) 
344 patients Rate of primary 
non-adherence 
before and after 
electronic 
prescribing 
Patients follow 
up interviews 
occurred 
between 6 – 14 
days after 
physician’s visit 
- One 
ambulatory 
care clinic 
- Discharge 
summary and 
patient’s 
phone 
interview 
- Primary non 
adherence rate: 
-  6.9% before e-
prescribing 
- 10.6%, 6 months 
after e-prescribing 
- 2.5%, 12 months 
after e-prescribing 
 
Streeter 
et al 2011 
- Cross sectional 
cohort study 
- Cancer patients 
with new 
prescription for an 
10,508 
patients 
Rate of 
prescription 
abandonment 
for newly 
initiated oral 
90 days Pharmacy 
claims 
database 
- Prescription 
abandonment rate = 
10% 
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oral oncolytic agent oncolytic agent 
(reversed 
claims) 
 
Gleason 
et al 2009 
 
 
 
 
 
 
 
 
 
 
- Cross sectional 
study 
- Patients with 
newly initiated MS 
therapy  or TNF 
blocker agent 
10,104 
patients 
Association 
between out of 
pocket OOP 
payments and 
rate of 
prescription 
abandonment 
for newly 
initiated MS or 
TNF blocker 
therapy 
(reversed 
claims) 
 
90 days Pharmacy 
claims 
database 
- Prescription 
abandonment rate 
increased as OOP 
payments 
increased: 
- MS therapy: (5.7 
%– 28.5%) 
- TNF blocker: 
(4.7% - 26.4%) 
Papke JA 
1999 
 
 
 
- Cross sectional 
study 
- New prescriptions 
that are filled 
(prepared), but 
unclaimed 
18,233 
prescriptions 
Rate, and cost 
of unclaimed 
prescriptions 
 
5 days -Outpatient 
hospital 
pharmacy 
-  Hospital 
database and 
patients’ 
interview 
 
- Rate of 
unclaimed 
prescriptions = 
4.72% 
- Cost/unclaimed 
prescription = 
$4.99 
 
 
Fischer 
et al 2010 
 
- Cross sectional 
cohort study 
 
195,930 
prescriptions 
Rate of primary 
non-adherence 
Open period 
(until the end of 
data collection 
period) 
- Outpatient 
clinics 
-  Electronic 
prescribing 
transactions 
- Pharmacy 
claim 
- Rate of primary 
non-adherence= 
28.3% 
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database 
 
Jackson 
et al 2014 
- Cross sectional 
cohort study 
- New prescriptions 
for chronic 
diseases 
29,238 
prescriptions 
Rate of primary 
medication non-
adherence 
30 days - 100 retail 
pharmacies 
- A large 
national 
pharmacy 
chain 
database 
 
- Rate of primary 
medication non-
adherence  = 
12.2% 
Reabel et 
al 2012 
- Cross sectional 
cohort study 
- Patients with 
newly initiated 
prescriptions for an 
antihypertensive, 
antidiabetic, or 
antihyperlipidemic 
medication 
12,061 
patients 
Rate of primary 
non-adherence 
30 days - Integrated 
healthcare 
system 
 
- Electronic 
medical 
records 
- Pharmacy 
information 
management 
system 
 
- Rate of primary 
non-adherence: 
- 7% for 
antihypertensive 
group 
- 11% for 
antidiabetic group 
- 13% for 
antihyperlipidemic 
group 
Shin et al 
2012 
- Cross sectional 
cohort study 
- Newly initiated 
electronic 
prescriptions for 
acute and chronic 
diseases 
569,095 
prescriptions 
Rate of primary 
medication non-
adherence 
14 days -Pharmacies 
at 14 medical 
centers 
- Electronic 
medical 
records 
 
- Overall primary 
non-adherence 
rate = 9.8% 
Kennedy 
et al 2008 
- Cross section 
survey 
- Medicare 
beneficiaries aged 
14,464 
patients 
Rate of unfilled 
(abandoned) 
prescriptions 
Undetermined - Medicare 
Current 
Beneficiary 
Survey 
- Overall rate of 
unfilled 
prescriptions = 
4.4% 
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≥18 years old (MCBS) 2004 
data 
 
Fischer 
et al 2011 
-Cross sectional 
study 
- All patients having 
CVS Caremark’s 
PBM drug coverage 
423,616 
prescription 
Rate of primary 
non-adherence 
Up to six 
months after 
prescribing 
-Outpatient 
settings 
- Electronic 
prescribing 
database 
-  pharmacy 
benefit 
management 
database 
 
- Rate of primary 
non-adherence = 
24% 
Ding et al 
2013 
-Cross sectional 
study 
 
- Patients aged ≥ 
18 years old 
discharged from 
emergency 
department with 
Medicaid coverage 
1026 patient Determine  
the validity of 
self-reported 
primary non-
adherence 
(new and refill 
prescriptions) 
30 days - Emergency 
department at 
three 
hospitals 
- Medicaid 
pharmacy 
claims 
database 
- Emergency 
department 
information 
system 
- Patients’ 
interview 
 
- Rate of primary 
non-adherence  = 
26% 
- Patients’ reported 
data had high 
sensitivity; 
however, low 
specificity: 
- Sensitivity: report 
filling a prescription 
for prescriptions 
with pharmacy 
claims 
- Specificity: report 
not filling a 
prescription for 
prescriptions 
without pharmacy 
claims 
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* RTS = Returned to stock
Thomas 
et al 2006 
- Cross sectional 
survey 
- Adults ≥18 years 
3,926 
patients 
Primary non-
adherence 
(new and refill 
prescriptions) 
Undetermined - Medical 
care centers 
in rural areas 
of 8 
southeastern 
states 
- 21.6% delay or 
not fill a 
prescription in one 
year 
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Summary of literature  
 
     Before discussing the literature, a point must be clarified about terminology. When 
looking at the literature,  the terms prescription abandonment and primary non-
adherence overlap in studies that analyzed electronic prescriptions. With e-prescribing, 
it is difficult to differentiate between prescription abandonment and primary non-
adherence because primary non-adherence will result eventually in prescription 
abandonment. However, prescription abandonment and primary non-adherence are two 
different terms. Primary non-adherence is related to newly initiated prescriptions, and 
prescription abandonment includes both new and old prescriptions. For electronic 
prescribing, however, the two terms end up being the same thing.  
 Filled prescriptions 
 
Percentage of Abandoned Prescriptions 
     A study by Shrank et al (2010) evaluated the rate and predictors of abandoned 
prescriptions at a large national pharmacy chain (CVS) and a large national pharmacy 
benefit manager (Caremark).15 The study outcome measures which are important for 
modeling medication waste are the rate at which prescriptions are filled, rate of 
abandoning a prescription with return to stock, and rate of abandoning a prescription 
with return to stock then purchasing it later. Authors estimated that the rate of 
prescription abandonment with return to stock was 3.27% with 1.5% of abandoned 
prescriptions re-purchased at a later date.  
     The study estimated an approximate cost of $5 per each abandoned prescription 
and concluded that the total annual cost of abandoned prescriptions at U.S. pharmacies 
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was more than $500 million. This total only reflected the cost of dispensing and did not 
consider other incurred costs such as the cost of a physician’s visit or resource use 
associated with negative health outcomes. In addition, the reported abandonment rate 
only refers to retail pharmacies and may differ from rates at other outpatient 
pharmacies. A study by Bergeron et al (2013) investigated the rate of abandoning new 
prescriptions after implementation of electronic prescribing in one ambulatory care 
clinic.16 Three patient cohorts were studied: 6 months before e-prescribing, 6 months 
after e-prescribing, and 12-18 months after e-prescribing. The prescription 
abandonment rate was 6.9% before e-prescribing; increasing to 10.6% after 6 months 
of e-prescribing, and stabilizing at 2.5% after 12-18 months. The final rate of 2.5% was 
comparable to 3.27% rate obtained by Shrank et al, but was limited to abandonment of 
newly initiated prescriptions. 
     Two other studies investigated the rate of prescription abandonment for newly 
initiated prescriptions. Streeter et al (2011) utilized data from a nationally representative 
pharmacy database to look at the effect of copayments on abandoning of newly initiated 
prescriptions for eight common oncolytic agents.17 An abandoned prescription was 
defined as a prescription that is submitted to the pharmacy and has a reversed claim 
with no follow up claim. It was found that copayments were significantly associated with 
the prescription abandonment estimate of 10%. This rate was higher than other studies 
possibly due to the cost of the drugs and the study population.  
     Gleason et al (2009) examined the rate of abandoned prescriptions among newly 
initiated prescriptions for two sets of specialty drugs: TNF blocker therapy and MS 
therapy.18 Data for the study came from a database from eight commercial health plans. 
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A trend analysis of the association between copayment and prescription abandonment 
rate found that prescription abandonment rate increased with copayments resulting in 
an abandonment rate of 4.7% to 26.4% for TNF blocker therapy and 5.7% to 28.5% for  
MS therapy.  
     In summary, the rate of abandonment of prescriptions in community settings ranged 
from 3.27% to 10% for most drugs. Abandonment of specialty medicines was much 
higher due to special circumstances associated with these drugs such as large co-
payments.   
     Among the encountered studies in the literature review, only one attempted to 
estimate the cost of abandoned prescriptions. A single hospital outpatient pharmacy in 
Texas (1999) estimated its annual cost of abandoned prescriptions at more than 
$60,000 although this finding may not be externally valid to other settings.18  
Unfilled  prescriptions  
  
     There are two types of unfilled prescriptions. Unfilled prescriptions for newly initiated 
medications are called primary non adherence. Unfilled prescriptions for refills fall into 
the category of secondary non-adherence which is defined as filling a prescription but 
not taking it as prescribed. 
Primary non-adherence 
     Four studies examined primary non-adherence in outpatient settings. Three 
examined primary non-adherence in prescription claims data and the fourth used a 
pharmacy database, allowing it to account for cash prescriptions.20 
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     Fischer et al (2010) found that the rate of primary non-adherence in outpatient clinics 
with different specialties was 28.3%. Primary non-adherence was defined as rate at 
which patient did not fill new prescriptions.21 Multivariate analysis showed that 
prescriptions of chronic diseases including antihypertensives, antidiabetics, and 
antihyperlipidemics were less likely to be filled compared to antimicrobial agents. This 
may suggest that patients are concerned with quick relief of symptoms rather than long 
term effects. In addition to primary non-adherence, the study estimated the rate of 
prescription non-fulfillment among all issued prescriptions to be 22.5%. 
     Jackson et al (2014) estimated that primary non-adherence in prescription 
medications of chronic conditions across 100 pharmacies was 12.2%.20 This estimate 
used pharmacy dispensing data which accounted for cash and non-cash claims but only 
examined prescriptions for chronic diseases. Primary non-adherence was defined as a 
new electronic prescription for a patient aged 18 years and older that is not obtained 
within 30 days.  
      Raebel et al (2012) looked at primary non-adherence in an integrated healthcare 
system among three classes of medications: antidiabetic, antihypertensive, 
antihyperlipidemic and a fourth class of multiple medications use.22 Primary non-
adherence was defined as not picking up a new prescription medication within 30 days 
of order. The rate of primary non-adherence was significantly different between the 
three therapeutic groups: 7% for antihypertensives, 11% for antidiabetics, and 13% for 
antihyperlipidemics. 
     A study by Shin et al (2012) also used data from an integrated health system and 
found a similar estimate of primary non-adherence rate (9.8%) as Raebel et al.90 
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However, it examined primary non-adherence for drug classes used to treat both acute 
and chronic conditions.  
     In summary, definitions of primary non-adherence only varied slightly in the 
literature, and studies found that the rate of primary non-adherence varied between 7% 
and 28%. Lower percentages were reported in integrated health systems, where there 
is more focus to provide better services to patients. Higher percentages were reported 
from data drawn from populations which were not nationally representative. The 
estimate of primary non-adherence rate by Jackson et al (12.2%) was based on 100 
retail pharmacies and considered the best estimate for the base case of the model.  
Unfilled prescriptions  
     Three studies looked at unfilled prescriptions for both new and old prescriptions. The 
first study conducted by Kennedy et al (2008) addressed unfilled prescriptions among 
Medicare beneficiaries in community settings.23 In the 2004 Medicare Current 
Beneficiary Survey (MCBS) Access to Care Survey, 4.6% of participants answered yes 
to the question “During the current year, were there any medicines prescribed for you 
that you did not get?” It was estimated that 4.4% (1.6 million) of all Medicare 
beneficiaries in the United States do not fill their prescriptions. 
     Fischer et al (2011) examined the rate of unfilled prescriptions by linking data from a 
national electronic prescribing system with claims data from a large national pharmacy 
benefit manager database.91 Primary non-adherence was estimated as 24%, but 
including refill orders decreased the percentage of unfilled prescriptions to 14.5%.  
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     The third study assessed self-reported prescription filling after an emergency 
department visit among Medicaid enrollees, comparing it to the pharmacy claims data 
as the gold standard.24 According to patients, 90% of the prescriptions were filled (i.e. 
obtained by patients), but pharmacy claims data indicated that only 74% of the 
prescribed medications were filled. This indicates that self-report is not an accurate 
measure of prescription fulfillment. 
Unfilled prescriptions 
  
     One study of patients not filling of handwritten prescriptions was conducted by 
Thomas et al (2006).25 A telephone survey assessed primary non-adherence in a rural 
population to examine the effect of patient satisfaction with care and the quality of 
patient-physician relationship on patients’ delay or failure to fill a prescription. The 
overall estimated rate of primary non-adherence based on patients’ reports on unfilled 
prescriptions was 21.6% among study participants. This estimate may not be nationally 
representative because it was limited to rural areas where there are fewer pharmacies, 
difficulties in transportation, people with lower education levels and lower incomes.  
Part 2: Literature review on unused prescription medications 
 
     The published literature on unused prescriptions covers a broad range of topics 
including quantifying the amount of unused prescription medications, storage and 
disposal practices at households, and possible consequences of unused prescription 
medications (water pollution, health impact, cost to healthcare system, non-medical use, 
medication sharing, and diversion). This literature review focused on quantifying unused 
prescription household medications and those returned to pharmacies. Studies 
associated with unused prescription medications in institutional settings like hospital in-
 
   
28 
 
patient and nursing homes care were not considered. Search terms used are 
summarized in Table 2.3 and the literature search is summarized in Figure 2.2. Titles 
and abstracts of articles were checked for inclusion and exclusion criteria. The overall 
search revealed 474 articles. References from the included articles were also reviewed 
for additional relevant articles. After applying inclusion and exclusion criteria and 
eliminating duplicates, 13 unique eligible articles were found.92-104 Of these, 6 articles 
were selected for discussion (Table 2.4), because they were the most recent, were 
more generalizable to national settings, and addressed costs as well as quantifying the 
amount of unused prescription medications.  
Table 2.3. Search terms history for unused prescription medications 
Search term Eligible articles Total 
 
Unused prescription medications 
Unused medications 
Wasted medications 
Unique eligible articles 
PubMed 
1 
2 
1 
 
 
IPA 
6 
8 
1 
 
 
CINHAL 
1 
4 
- 
 
 
 
 
 
13 
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Figure 2.2 Flow chart summary of literature search 
      
     The literature revealed limited research about unused prescription medications in 
outpatient settings. The articles can be divided in to two parts: unused prescription 
medications in households and unused prescription medications returned to a pharmacy 
or medication take back event.
Articles retrieved based on search 
terms 
n= (474) 
Excluded reports and articles 
that: 
-did not meet the 
inclusion/exclusion criteria 
-were not available 
n= (450) 
 
 
 
Eligible original research articles 
n= (24) 
Unique eligible original research 
articles 
 n= (13) 
Eliminated duplicates 
 n= (11) 
Articles selected for discussion 
n= (6) 
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Table 2.4 Summary of included articles of unused prescription medications 
Author Study design and 
sample 
Sample 
size 
Outcome measure 
of interest to our 
model 
 
Setting and data 
source 
Findings relating to 
our research 
Wieczorkiewicz 
et al 
2013 
- Phone survey 
- Adults ≥ 18 years 
old 
445 surveys To determine 
households’’ use, 
store, and dispose 
of medications 
 
- Patients were 
phone interviewed 
- Average number of 
prescription 
medications was 4.4 
- 30% of respondents 
do not use their 
prescription 
medications regularly 
- 23% have expired 
prescription 
medications 
 
Lewis et al 
2014 
- Survey (face to 
face interviews) 
- US veterans 
 
191 
participants 
Investigate use and 
disposal of 
prescription opioids 
- Veterans Affairs 
Palo Alto Health 
Care System 
(VAPAHCS) 
- Electronic 
medical records 
- Patients’ 
interviews 
 
- 65.4% of patients 
store unused 
prescription opioids 
- Only one third of 
patients used all 
prescribed opioids or 
discarded unused 
Bates et al 
2011 
- phone and mail 
survey 
- Adult patients who 
underwent 
urological surgery 
275 
participant 
- Patients’ 
satisfaction with 
pain 
 
- use and disposal 
of narcotics 
- Chart review 
- Phone interview 
- Patient 
administered 
questionnaire 
- 67% of patients have 
leftover medications 
- 90.8% of patients 
stored leftover 
medications 
Morgan TM - Cross sectional 73 - Assessed - One retirement - Total cost of wasted 
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2001 survey 
- Elderly residents 
age ≥ 65 years old 
participant prescription 
medications use 
community 
- Patients home 
interview 
- Pill sort at 
patients’ homes 
 
medications = $2011 
- Average annual cost 
per person = $30.47 
(2.3% of the total 
annual costs per 
person) 
 
 
Perry et al 
2014 
- Prescription 
medications take 
back event 
- Patients’ survey 
 
818 surveys - Quantify 
medication waste, 
cost, and assess 
disposal practices 
- One local 
community 
- Event held for 7 
days 
- Patient’s 
administered 
survey 
 
-  More than 780 
thousand wasted 
dosing units with a 
total cost of more than 
$1 million 
Garey et al 
2004 
- Community 
campaign 
- Patients returning 
prescription and 
over the counter 
medications 
- - Investigate 
quantity, cost, and 
types of returned 
medications 
- One community 
pharmacy 
- 1315 medication 
containers were 
returned 
- 65% of returned 
medications were 
prescription 
medications 
- Total cost of returned 
medications = $26,222 
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Unused prescription medications in households 
 
     Four studies assessed the non-use of prescription medications among adult 
population (aged 18 years and above). Three of the four studies used phone or mail 
surveys to collect data, 92,93,94 and the fourth used both patient surveys and a home 
visit.95 
     Wieczorkiewicz et al (2013) investigated unused medications (prescription and non-
prescription) in households in Cook County, Illinois.92 A phone survey revealed that 
about one third of patients did not use their medications regularly and expired 
prescription medications accumulated in 23% of the study participants. The monetary 
cost was not quantified.  
     Lewis et al (2014) investigated unused prescription opioids among a veteran 
population.93 Stockpiling of unused opioids was reported by 65% with only 6.3% of 
patients disposing of unused opioids. Stockpiling opioids was associated with 
recreational use of these medications in 34% of patients. A similar study by Bates et al 
(2011) investigated unused narcotics among discharged patients who underwent 
surgery.94 In this study, 67% of patients stockpiled unused narcotics. 
     Combining home visits with questionnaires, Morgan (2001) found that 52% of 
patients in a retirement community wasted 2078 doses of prescription medications (i.e. 
medicines kept with no intention to use).95 The total cost of waste was $2011 for the 
study group and the average annual cost of wasted prescriptions per participant was 
estimated at $30.47. The study looked at both the amount and the cost of wasted 
prescription medications, but did not examine wasted physician or pharmacist time.  
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     A news release in 2006 showed results of a national prescription drug survey 
conducted by The National Community Pharmacists Association (NCPA) in 
collaboration with Pharmacists for the Protection of Patient Care (P3C) group; the 
survey revealed that 49% of patients forgot to take at least some of their prescribed 
medications and 24% took less than the prescribed doses.96  
Unused prescription medications returned to a pharmacy or a medication take 
back event 
     Several studies examined medications collected in take back events.97,98,99,100 These 
studies quantified the amount of unused or expired medications collected, estimated 
their associated cost, and surveyed patients about reasons behind non-use. Perry et al 
(2014) described 7 prescription medication take back events that were held in a local 
community in Ohio.101 This study was the largest of its kind and included all dosage 
forms when estimating cost. 800,000 dosing units were collected over 7 days with an 
estimated average wholesale cost of more than $1 million.  
    A study of dropped-off unused medications by Garey et al (2004) in Houston, Texas 
found that the majority (65%) of unused medications were prescription medications.102 
The estimated cost of all unused medications returned to the pharmacy was more than 
$26,000.  
     A newly published study (2014) investigated unused medications at households in a 
local community.103  In phase 1 of the study, a web survey was conducted; the results 
showed that the ratio of unused to used medications was 2:3 with an estimated cost of 
unused medications at more than $23,000. In the second phase, a paper based survey 
among patients who returned unused medications to community pharmacies was 
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conducted. A total of 776 unused medications where returned for disposal at an 
estimated cost of more than $59,000. The total cost of unused medications among 
adults was extrapolated to be $117.5 billion on the national level. 
Overview of the literature 
 
     Studies of unfilled, abandoned prescriptions, and unused prescription medications 
can allow a model of medication waste to be developed. Only some of the data in the 
literature is nationally representative but assumptions and sensitivity analyses can be 
used to deal with sources of variability in the data. Using estimates of waste in the 
literature, costs can be assigned to estimate the total direct costs associated with 
wastage in delivery of care attributed to medication waste. 
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 Chapter 3 
 
 
 
Methods 
 
 
 
     Study design 
 
     A cost of illness model was developed using data from the literature, and a 
retrospective cross sectional study of the Medical Expenditure Panel Survey (MEPS) 
2012 was conducted. The MEPS is a nationally representative database of the civilian, 
noninstitutionalized population of the United States. In the model, direct medical costs of 
medication waste (exclusive of impact on health outcomes) were investigated. Indirect 
and intangible costs are not considered. Direct medical costs of unfilled, abandoned 
prescriptions, and unused prescription medications were estimated over a one year 
period using a bottom up approach. All cost estimates were converted to 2014 values 
by applying yearly healthcare inflation rates. Prevalence estimates of unfilled, 
abandoned prescriptions, and unused prescription medications for U.S. population were 
considered in the current study. 
Economic model:  
Direct medical costs associated with wastage in delivery of care due to medication 
waste are illustrated in Figure1.1 (repeated here for convenience of the reader).
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Figure1.1 Model of the medication use process: underlined words represent points 
where direct medical costs are incurred. 
 
 
Points at which prescription medication waste is identified are: 
1. Not filling a prescription (Cost of physician time writing a prescription) 
2. Abandoning a prescription (Cost of physician time writing a prescription and a 
pharmacist's time preparing the prescription) 
3. Picking up a prescription, but not using the prescribed medications (Cost of 
physician time writing a prescription, a pharmacist's time preparing the 
prescription, and the cost of the medications dispensed but not used as directed) 
Model assumptions 
 
The model was built on the following assumptions: 
1. 100% of prescriptions transmitted electronically or via fax or phone were by 
pharmacists without any action from the patient. 
2. For handwritten prescriptions, only those hand-delivered to the pharmacy were 
filled by the pharmacist 
Physician writes 
a prescription
Filled 
(prepared)
Abandoned
Picked up
Used
Not used
Unfilled (not 
prepared)
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3. The rate of unfilled prescriptions was the same as rate of abandoned 
prescriptions based on the fact that abandoning a prescription and not delivering 
a handwritten prescription to the pharmacy are two separate consequences of 
patient’s intention to not fill (obtain) the prescription. The difference between the 
two is the nature of the transmittal process of the prescription (i.e. electronic, fax, 
phone or hand-delivery) 
4. A prescription was considered abandoned after two weeks of delivery to the 
pharmacy.  
5. Every abandoned prescription was returned to stock  
6. Prescriptions with automatic refills were excluded from the model 
7. Unused prescription medications were a result of patients’ non-adherence to 
drug therapy (i.e. patients do not consume the entire quantity prescribed, leading 
to unused leftover medications).   
8. A one year period was the time frame of the study 
9. The rate of unfilled, abandoned, and unused prescriptions was considered 
constant throughout the study period. 
Data sources 
  
Prescription data 
     The total number of prescriptions written in outpatient settings for the year 2012 was 
obtained using steps 1 and 2 below: 
1. The total number of office based visits, outpatient visits, and emergency room 
visits involving written prescriptions was drawn using the variable (MEDPRESC) 
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in the three MEPS data files: Office-Based Medical Provider Visits, Outpatient 
Visits, and Emergency Room Visits files 
2. The total number of prescriptions written in outpatient settings was obtained by 
multiplying the total number of all visits involving written prescriptions (in step 1) 
by the average number of prescriptions per visit. The National Ambulatory 
Medical Care Survey (NAMCS) and The National Hospital Ambulatory Medical 
Care Survey (NHAMCS) were used to calculate the average number of 
prescriptions written per office based visit, hospital outpatient visit, and 
emergency room visit.104,105,106  
     In 2012, the total number of office based visits, hospital outpatient visits, and 
emergency room visits that involved written prescriptions reported in MEPS was 
277,226,561 visits. According to NAMCS and NHAMCS, the average number of drug 
mentions in one visit varied between 3.4 for office-based visits (2010)104, 3.6 for hospital 
outpatient visits (2011) and 2.6 for emergency room visits (2011).105,106 In our base case 
model, we assumed the average number of prescriptions written in a single visit at a 
conservative total of three. This was done to take into account the fact that some office 
based visits include prescriptions for medications that are not self- administered by 
patients such as immunizations and other injectables. When the average number of 3 
was multiplied by the total number of outpatient visits involving written prescriptions for 
the year 2012 (277,226,561), we ended up with a total of 831,679,683 prescriptions per 
year. This number was multiplied by the assumed rates of unfilled prescriptions, 
abandoned prescriptions, and prescriptions dispensed but not used to get their 
respective totals. 
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Prevalence estimates 
The rate of abandoned prescriptions use in the model was based on the Shrank et al 
study (2010) which investigated the rate of prescription abandonment in a large chain 
community pharmacy.15 This study was chosen because it examined abandonment of 
new and refill prescriptions as well as prescriptions delivered electronically or by hand. It 
also used data from a large national pharmacy chain and a large national pharmacy 
benefit manager, providing a rate of abandoned prescriptions that should be nationally 
representative.  
     The average rate of prescription medications dispensed but not used as directed 
was obtained from Claxton et al (2001)107.This paper was a systematic review which 
assessed adherence using electronic monitoring devices. Patients’ adherence was 
assessed by looking at whether the appropriate number of doses were taken during 
each day or not. The study reported an average rate of adherence of four dose 
regimens across a variety of therapeutic classes. Although the review was in 2001, it 
was the only encountered study that provided an average rate of unused acute and 
chronic medications. The average rate of non-adherence was 29%.  
Cost data 
     Costs of office-based physicians’ visits and other outpatient visits came from 
Medicare reimbursement costs for physicians’ fees obtained by using Current 
Procedural Terminology (CPT) codes. CPT codes were used to identify physicians’ 
visits involving an order for a prescription, however, no specific CPT codes were 
available for such visits. So, CPT codes used were:  99203 (a physician visit for a 
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condition of low to moderate patient severity level and a medical decision of low 
complexity for new patients) and 99213 (a physician visit of low to moderate patient 
severity level and a medical decision of low complexity for established patients).108  CPT 
codes for non-facility based visits were used because most of prescriptions are 
generated during office based visits. Average reimbursement of the two codes was 
used in the model.  
     Average dispensing cost was based on a national study which estimated the national 
average cost of dispensing per prescription incurred by community retail pharmacies.109 
Cost of dispensing incorporated direct costs, salary expenses, and overhead 
costs.109,110 
     The average prescription cost was obtained from MEPS using the variable 
(RXXP12X) from the prescribed medicines file (2012), which represents the mean total 
payments (from 12 sources of payments) per each purchased prescription. 
Cost calculation 
  
Overall cost of medication waste 
     A prevalence based method was used to estimate the economic burden of 
medication waste. In this method, the prevalence of wasted prescriptions (either 
unfilled, abandoned, or unused prescription) during a specific time period (one year) 
was measured and assigned a cost using a bottom up approach. In this approach, the 
mean cost per unit is calculated and multiplied by the total number of units. Total costs 
for unfilled, abandoned, and unused prescription were summed together to obtain the 
overall cost. 
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Specific objective 1: 
 
To estimate the annual direct medical costs of medication waste in delivery of care with 
regard to unfilled and abandoned prescriptions. The variables considered for estimating 
the direct medical costs per an unfilled and abandoned prescription are listed in Table 
3.1. 
Table 3.1 Cost variables of unfilled and abandoned prescriptions 
Cost variable Costs associated 
with unfilled 
prescriptions 
Costs associated with 
abandoned 
prescriptions 
 
Mean cost of office based 
physicians' visits and other 
outpatient visits^ 
 
* * 
Mean dispensing cost 
 
 * 
 ^Mean cost of office based physician’s visit and other outpatient visits is computed 
based on Medicare reimbursement of physicians’ fees. An average of the average cost 
of both new and established patients’ visits is calculated and used. Reimbursement for 
other components of physicians’ visits like diagnostic procedures, laboratory services 
and prescribed medications are not considered as they don’t fit to the cost of unfilled 
and abandoned prescriptions.  
 
Specific objective2: 
To estimate the annual direct medical costs of medication waste in delivery of care with 
regard to unused prescription medications. The variables considered in estimating the 
direct medical costs per an unused prescription are: 
- Mean cost of office based physician’s visit and other outpatient visits 
- Mean prescription cost  
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Data analysis 
 
     Data were analyzed by decision analysis performed using the TreeAge software, Inc. 
v14 for Healthcare. A decision tree was built (see Figure 3.1) mapping out the possible 
outcomes of writing a prescription by a physician and assigning probabilities that 
unfilled, abandoned, and unused prescription medications will occur as well as its 
average cost (in dollars). A folding back technique was used to estimate the expected 
value (weighted average cost) per wasted prescription (either unfilled, abandoned, or 
unused prescription). This technique works by multiplying the probability that each 
outcome will occur by its cost and it starts from the right side of the decision tree (Figure 
3.1) and works leftward. Mean cost per unfilled, abandoned, and unused prescription 
was also provided at terminal nodes (indicated by triangles at the end of the tree). 
 
Figure 3.1 Decision tree analysis: outcomes that don’t represent medication waste are 
assigned zero values; arrow represents point where average weighted cost per 
prescription is estimated  
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Sensitivity analyses  
 
     One way sensitivity analysis and probabilistic sensitivity analysis (PSA) were 
performed using the TreeAge software. The aim of these sensitivity analyses was to test 
the robustness of the estimated average cost of medication waste. This is due to 
uncertainties in the selected parameter estimates such as cost or probabilities of 
events. A tornado diagram was made to illustrate the sensitivity of the estimated cost to 
the variables used in the model. 
     In one way sensitivity analysis, the value of one variable is varied in the model while 
keeping values of other variables constant. To determine variable ranges used in the 
sensitivity analysis, 95% confidence interval limits were used when possible. When no 
confidence intervals or standard deviations were reported, the highest and lowest value 
estimates reported in the literature were used. When neither of these options were 
available, averages for variables were increased and decreased by 20%. 
     For unused prescription medications, Claxton et al provided a wide range of values 
(from 3% to 66%). This was considered too wide for a sensitivity analysis, so a ±20% 
range was used.  
     The rate of abandoned prescriptions also had a wide range in the literature (from 
3.27% to 28.3%). The upper range reported by Fischer et al (2010) was not used 
because it was not nationally representative. Therefore, the rate of 14.5% reported by 
Fischer et al (2011) was used as the upper limit for abandoned prescription rate.  
     The average prescription cost was reported in MEPS along with the standard error, 
so a 95% confidence interval was used as the range for the sensitivity analysis. The 
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average cost of physician’s based office visit and other outpatient visits was varied 
between zero and the base case value.  Average dispensing cost, average number of 
prescriptions written per visit and total number of visits involving written prescriptions 
were varied over ±20% range. 
     In PSA, the combined uncertainty of all variables included in the model was tested 
using Monte Carlo simulation. Each parameter estimate (for example mean dispensing 
cost) was assigned a probability distribution and the software randomly picked a value 
for each estimate (for all estimates at the same time) from its distribution to calculate the 
mean cost of waste prescription. This process was repeated many times to calculate a 
distribution probability for costs of medication waste. In our model, beta distribution was 
assigned for outcomes’ probabilities and gamma distribution for cost variables. Beta 
distribution limits the output to values between 0 and 1 making it suitable for probability 
outcomes. Gamma distribution is recommended for modeling non-negative data such 
as cost. When assigning distributions, the mean was set to be equal to the base line 
value and the standard deviation was calculated based on the following formula: Upper 
limit – lower limit / (2X1.96).111 
     The process of running the model was repeated with different combinations of 
parameter estimates at each time providing the mean of the expected value of the cost 
of a wasted prescription.  Table 3.2 lists the baseline values and ranges for all variables 
included in one way sensitivity analyses and the distributions assigned to each variable 
in probabilistic sensitivity analysis.  
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Table 3.2 Key variables and ranges used in one way sensitivity analysis 
Variable  Baseline Source  Range 
 
 Source   Distribution 
assigned 
for PSA 
 
Mean office 
based 
physician’s 
visit and 
other 
outpatient 
visits cost* 
 $30**  CPT 
(2014) 
  ($0 – $30)**   ***   Gamma 
Mean 
dispensing 
cost 
 $14 National 
cost of 
dispensing 
study 
(2007) 
 
 ($11 – $17)** 
 
 ***   Gamma 
Mean 
prescription 
cost 
 
 $96 MEPS 
(2012) 
 ($90 – 
$102)** 
 
 MEPS   Gamma 
Probability 
of 
abandoned 
prescriptions 
 
 0.033 Shrank et 
al (2010) 
 (0.026 - 
0.04) 
 *** 
Fischer 
et al 
(2011) 
 
  Beta 
Probability 
of unused 
prescriptions 
 
 0.29 Claxton et 
al (2001) 
 (0.232 – 
0.348) 
 ***   Beta 
Probability 
of unfilled 
prescriptions 
 
 0.033 -  (0.026 - 
0.04) 
 ***   Beta 
Average 
number of 
prescriptions 
written per 
visit 
 
 3 NAMCS 
/NHAMCS 
 (2.4 – 3.6)  ***   - 
Total number 
of visits 
involving 
written 
prescriptions 
 
 277,226,561 MEPS  (221,781,249 
- 
332,671,873) 
** 
  
 
*** 
   
 
- 
*(Average cost of office based and other outpatient visits for new patient + average cost of office 
based and other outpatient visits for established patient) divided by 2: (106.1 + 71.81)/2 = 
 
   
46 
 
88.955; however, $29.7 was used in the model based on the assumption that three 
prescriptions are written per visit  
**Rounded to the nearest whole number  
*** ±20% was used due to lack of data 
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Chapter 4 
 
 
 
Results 
 
 
 
Base case analysis 
 
An estimated 831,679,683 prescriptions were written in outpatient settings in 2012. The 
total number of unfilled, abandoned, and unused prescriptions is summarized in Table 
4.1. Data were analyzed by decision analysis modeling and the base case results are 
shown in Figure 4.1. The weighted average cost per wasted prescription (either unfilled, 
abandoned, or unused prescription) is $37; mean cost per unfilled, abandoned, and 
unused prescription is $30, $44, and $126, respectively. The total annual direct medical 
costs associated with wastage in delivery of care attributed to medication waste is 
estimated at $30.4 billion. Table 4.2 shows a breakdown of overall cost by waste 
component; unused prescription medications contribute to more than 93% of the overall 
cost.
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 Table 4.1. Total number of unfilled, abandoned, and unused prescriptions 
 Method of calculation Total number of 
prescriptions 
 
Unfilled 
prescriptions 
0.033* X total no. of written 
prescriptions (831,679,683***) 
 
27,445430 
Abandoned 
prescriptions 
0.033* X total no. of filled       
prescriptions (804,234,253****) 
 
26,539,730 
Unused 
prescriptions 
0.29** X total no. of picked up 
prescriptions (777,694,523*****) 
 
225,531,412 
*Shrank et al (2010) 
** Claxton et al (2001) 
***Total number of physician visits (MEPS 2012) times 3 prescriptions per visit 
****Total number of written prescriptions times rate of filled prescriptions (0.967) 
*****Total number of filled prescriptions – total number of abandoned prescriptions 
 
Figure 4.1 Base case results using decision analysis modeling. The arrow indicates the 
weighted average cost per a wasted prescription.  
 
 
 
   
49 
 
Table 4.2. Overall cost by unfilled, abandoned and unused prescriptions* 
Cost component No. of occurrences in 
one year** 
Mean cost 
per event 
Annual direct 
medical costs 
(in millions)** 
 
Unfilled prescriptions 27,445,430 $30 $823 
Abandoned 
prescriptions 
26,539,730 $44 $1,168 
Unused prescriptions 225,531,412 $126 $28,417.0 
Total annual direct 
medical costs 
 
  $30,408 
*All costs are in US dollars 2014 values 
**Rounded to the nearest whole number 
 
Table 4.3 Total direct medical costs by type of visit 
 Office based 
visits 
Hospital 
outpatient visits 
Emergency 
room visits 
 
Number of visits involving 
written prescriptions 
 
244,286,605 12,433,294 20,506,662 
Number of prescriptions* 
  
732,859,815 37,299,882 61,519,986 
Annual direct medical 
costs** 
(in millions) 
 
$27,116 $1,380 $2,276 
Share of the total cost*** 
 
89.2% 4.5% 7.5% 
*No. of prescriptions = No. of visits involving written prescriptions X 3 
**Rounded to the nearest whole number 
***Numbers may not add to 100 due to rounding 
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Figure 4.2 Share of dispensing cost and ingredient cost to overall cost 
 
     The total estimated cost is also presented in terms of type of outpatient visit. The 
share of office based visits, hospital outpatient visits, and emergency room visits to 
overall cost is shown in Table 4.3. Prescriptions written in physician’s office account for 
most of the waste with an estimated cost of $27 billion.  
     The share of dispensing cost and ingredient cost was also calculated. The total 
average dispensing cost incurred by abandoned prescriptions and unused prescription 
medications was estimated at $3.5 billion, which represents 11.5% of the overall cost. 
The estimated average ingredient cost per prescription estimated was $82 and the total 
average ingredient cost was $18.5 billion, which represents almost 61% of the total 
estimated cost. Figure 4.2 shows the share of dispensing cost, ingredient cost, 
physician’s visit cost to overall cost.  
11%
61%
28%
Dispensing cost
Ingredient cost
Physician's visit cost
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Sensitivity analyses 
 
One way sensitivity analysis 
A Tornado diagram illustrated one way sensitivity analyses for all variables in the model 
(Figure 4.3). Overall cost was most sensitive to the average rate of unused prescription 
medications, costs per office based visits, and cost of the medications prescribed. 
Varying the probability of unused medications over ±20% range resulted in 
approximately ± $5.4 billion effect on overall estimated cost. When the mean office 
based visit cost varied between ($0 and $30), the total cost ranged from $21.6 billion to 
$30.8 billion. Mean prescription costs had an effect of ± $1.3 billion on the overall 
estimated cost. Mean dispensing costs, probability of medications being abandoned, 
and probability of prescriptions not being filled had little effect on overall costs of 
medication waste (Table 4.4).  
Probabilistic sensitivity analysis (Monte Carlo simulation) 
     A probabilistic sensitivity analysis (PSA) was conducted using all the variables in the 
model. A Monte Carlo simulation was run for 10 thousand iterations giving an average 
expected cost per wasted prescription of $37 (95%CI: $27 – $47) and thus, an overall 
cost of $30.4 billion (95% CI: $22.5 billion – $39.1 billion). Results of Monte Carlo 
simulation are summarized in Table 4.5.  
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Figure 4.4 One way sensitivity analysis on all variables: box represent range of values 
used in sensitivity analysis for each variable. 
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Table 4.4 Results of one way sensitivity analyses (USD 2014 values)* 
Variable Range Average cost 
per wasted 
prescription 
Total annual 
direct medical 
costs** 
(in millions) 
 
Mean office based 
physician’s visit and 
other outpatient visits 
cost 
 
($0 - $30) ($26 - $37) ($21,624 – 
$30,772) 
Mean dispensing cost ($11 – $17) ($36 – $37) ($29,940 – 
$30,772) 
 
Mean prescription cost 
 
($90– $102) ($35 - $38) ($29,109 – 
$31,604) 
 
Probability of 
abandoned 
prescriptions 
 
(0.026 - 0.04) ($37***) ($30,772) 
Probability of unused 
prescriptions 
 
(0.232 – 0.348) ($30 – 443) ($24,950 – 
$35,762) 
Probability of unfilled 
prescriptions 
 
(0.026 - 0.04) ($37***) ($30,772) 
Average no. of 
prescriptions written per 
visit 
 
(2.4 – 3.6) 
 
- ($24,618 – 
$36,927) 
Number of visits 
involving written 
prescriptions** 
 
(221,781,249 - 
332,671,873) 
 
- ($24,618 – 
$36,927) 
*USD: US dollars 
** Rounded to the nearest whole number 
***Varying the probability over the range (0.026 – 0.04) yields an average cost of 
wasted prescription of $37 
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Table 4.5 Results of probabilistic sensitivity analysis (USD 2014 values)* 
After 10,000 simulations Expected cost per wasted prescription 
Mean 
 
$37 
Median 
 
$36 
SD 
 
$5 
Minimum 
 
$22 
Maximum 
 
$58 
*USD: US dollars.
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Chapter 5 
 
 
 
Section 5.1: Discussion 
 
 
 
     This study examines medication waste associated with the medication use process. 
It quantifies the costs of medication waste in the United States exclusive of impact on 
health outcomes. It is unique in its exploration of the waste associated with wasted 
health care inputs including physician time spent diagnosing and prescribing for 
medications the patient does not use or uses inappropriately, time spent by pharmacists 
who fill prescriptions that are not picked up or taken incorrectly, and costs of 
medications which are dispensed but not taken as directed. 
     In this research, a model was developed which used a unique definition of 
medication waste. Other studies defined waste related to impact on health outcomes or 
environmental effects. This study defined medication waste in terms of waste in 
prescribing, dispensing, and non-consumption of medications. Therefore costs 
estimated in the study were specific to waste in delivery of care due to unfilled, 
abandoned, and unused prescription medications. Wastage in delivery of care means 
that healthcare personnel squander their time and efforts in activities that don’t result in 
any meaningful benefit to patients. In this study, the total estimated costs associated 
with such waste was $30.4 billion (95% CI: $22.5 billion – $39.1 billion). This sum
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excludes costs related to hospitalizations, physician visits, nursing home admissions, 
emergency department visits, and any additional resources used because of medication 
waste.  
     Unused prescription medications contributed most to the overall cost of medication 
waste.  Figure 5.1 illustrates the relative impact of each component on overall 
medication waste. Unused prescription medications accounted for most of the waste 
with a total cost of more than $28 billion. Improving medication adherence in patients 
can reduce this waste significantly.  
 
Figure 5.1 Relative impact of each component on overall medication waste 
 
     Compared to other studies that examined unused medications, this study used a 
novel approach. Other studies only included the ingredient cost of medications and use 
the Average Wholesale Price (AWP) to estimate the cost of unused 
medications.95,100,101,102 In contrast, we incorporated costs of dispensing and physician’s 
3%
4%
93%
Unfilled prescriptions
Abandoned prescriptions
Unused prescriptions
 
   
57 
 
visits as components of the overall cost of unused prescription medications. This 
captured waste in the medication use system that was ignored in previous research.   
    In addition, the data used for estimating the cost of wasted prescriptions was 
collected from nationally representative sources, something which most other 
encountered studies failed to do. Only two other studies attempted to quantify costs 
nationally. One used a single community pharmacy to extrapolate their findings 
nationwide.103 The other used a convenience sample of 73 New Hampshire retirement 
community residents to come up with an estimate of medication waste in senior 
populations.95  The causes behind medication waste are complex and varied. Individual 
characteristics of patients like physical impairments, cognitive problems, and age-
related concerns may prevent them from filling, picking up, or taking prescription 
medications as directed. The patient's medical condition (e.g., depression) may also get 
in the way. Structural barriers in the US Health Care System like inadequate continuity 
of care or poor provider–patient communications can prevent appropriate medication 
use. In addition, the complexity of therapeutic regimens, adverse effects associated with 
medication, and socioeconomic causes can reduce effective medication use. 
     Because of the complexity of causes behind medication waste, the solution will 
require diverse strategies that increase patient engagement and participation in their 
care. Reducing medication waste requires patients to fill, pick up, and take their 
medications. Health care providers like physicians and pharmacists can make the 
process easier, but patients must do their job too.  
     Improving relationships between patients and their providers, both physicians and 
pharmacists combined with systems that address the barriers to appropriate patient 
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behaviors can help reduce prescription drug waste. Innovations like appointment based 
medication synchronization can reduce medication waste.  
     Appointment based medication synchronization (ABMS) can reduce waste by 
allowing patients to meet with their pharmacists to solve medication-related problems 
and synchronize prescriptions to be dispensed on a single day of the month.112 
Significant improvement in medication adherence has been demonstrated with ABMS. 
Better adherence with ABMS may also be associated with less waste.  
     ABMS blends technology with face-to-face contact with pharmacists to address the 
causes of non-adherence and medication waste. It allows pharmacists to proactively 
manage patients' medication-related needs. ABMS provides the pharmacist an 
opportunity to engage in mutual problem solving with the patient about their medications 
and it can help resolve issues like simple forgetfulness, poor continuity of care, poor 
provider–patient communications, and insurance glitches. 
     Our definition of medication waste is unique. A study of medication waste conducted 
by the IMS institute published in 2013 estimated that $213 billion are wasted due to 
suboptimal use of medications.6 Waste was defined in terms of six areas listed in Table 
5.1. Medication non-adherence (primary and secondary) accounted for 50% of the total 
waste. For each area, costs were calculated based on increased utilization of four sites 
of care: hospitalizations, outpatient visits, pharmacy, and emergency room visits, which 
occurred as consequences of the suboptimal use of medications. Pharmacy utilization 
accounted for $22 billion (10%) of the total estimated cost; this is because more 
prescriptions are issued to patients with deteriorated health conditions as a result of 
medication non-adherence.  
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     Our study differs from the IMS study in the definition of medication waste and the 
related costs. Table 5.2 compared the different components considered by both studies.  
     This study has a number of limitations. The first was related to the specific types of 
costs we captured. We only looked at direct medical costs associated with wastage in 
delivery of care. There are other direct medical and non-medical costs as well as 
indirect costs that are related to the problem. These unaddressed costs include cost of 
impact on health outcomes, which may result from worsening health conditions; cost of 
impact on environment as a consequence of water and soil pollution; and cost of 
implementing strategies to overcome the problem such as medication take back events.  
Thus, our estimate of $30.4 billion represents only a small portion of the economic 
burden of medication waste, which may be addressed in future research.  
     Another limitation is that we were not able to determine what percentage of all 
dispensed medications are not used. We only captured the percentage of unused 
medications due to secondary non-adherence. This is because we obtained the rate of 
unused medications from a previous study that evaluated medication non-adherence. 
There is an undetermined percentage of unused medications caused by other factors 
such as treatment resistance, overprescribing, patients’ death, and others.  
     Another limitation  is the variability in our sources. Our data came from many 
sources -- some published and other from secondary databases. The challenge was to 
link the data from different resources and make them compatible. Also, some 
assumptions were made about variables because data was not available. We attempted 
to address issues of variability and compatibility in the sensitivity analyses. 
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     When conducting the study, our intention was to focus on patient’s role in leading to 
medication waste, more specifically, patients’ actions or non-actions in the medication 
use process. However, this was not necessarily met when we looked at unfilled and 
abandoned prescriptions. Patient’s intention to not fill or abandon a prescription could 
not be captured through the literature. In other words, such actions could happen as a 
consequence of other factors rather than patient’s intention to not use the prescribed 
medicine. These factors include the availability of medicine at home, physician’s 
instructions to not fill the prescription until the symptoms last for a number of days, or it 
could be the payer who refuses the prescription. 
     Also, it is possible that we overestimated the overall cost because we used 
physician’s visit costs as one of the costs associated with unfilled, abandoned, and 
unused prescriptions. However, there is still an economic value in the physician’s visit 
beyond writing a prescription. When physician’s visit cost was eliminated from the 
model in the sensitivity analysis, the overall estimated cost dropped by almost $9 billion, 
which constitutes approximately one third of the overall estimated cost.  
     Finally, there is limited generalizability of our results. We used data based on 
community pharmacies only and thus, it may not be applicable to other outpatient 
pharmacies.  
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Table 5.1 Areas of suboptimal use of medications and associated costs based on IMS 
study6 
Area Cost  
(In billion) 
 
Medication non-adherence $105.4 
Delayed evidence based treatment practice $39.5 
Antibiotic misuse $35.1 
Medication errors $20.0 
Suboptimal generics use $11.9 
Mismanaged polypharmacy in the elderly $1.3 
Total cost $213.2 
  
Table 5.2 Comparison between the current study and the IMS study 
 Type of waste Associated 
cost  
(in billion) 
 
Total estimated 
cost 
(in billion) 
Current 
study 
Unfilled prescriptions 
Abandoned prescriptions 
Unused prescription 
medications 
 
$0.8 
$1.2 
$28.4 
 
$30.4 
IMS study6 Hospital admissions 
Outpatient visits 
Prescriptions 
Emergency room visits 
 
$140 
$45 
$22 
$6 
 
$213 
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Section 5.2: Conclusion 
 
 
 
          Medication waste associated with unfilled, abandoned, and unused prescription 
medications is a significant burden on the US Healthcare System. Medication use 
process starts when a physician writes a medication prescription and ends by patients 
using or not using their dispensed medications. Patients who don’t fulfill their role in the 
medication use process cause a considerable amount of monetary wastage estimated 
in our study at $30.4 billion. Instead of being wasted, money spent on these avoidable 
costs could be used to treat a large number of patients. 
     There are different reasons that lead to medication waste; patients’ medication non-
adherence is the primary leader to such a problem. To reduce the intensity of 
medication waste, healthcare policy makers should focus on stablishing plans that help 
increase patient engagement in their care. 
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Section 5.3: Study implications 
 
 
 
     This study estimated the overall cost of medication waste considering only wastage 
inputs. Future studies that address medication waste considering other direct and 
indirect costs are needed to provide a more comprehensive estimate of the overall cost. 
     Our study is limited to waste in the United States healthcare system. Efforts should 
be increased to reduce waste in the US and worldwide.  
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